Benefits of ADHD Treatment in Detained People

PHASE3RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

October 30, 2025

Study Completion Date

October 30, 2026

Conditions
ADHD
Interventions
DRUG

Concerta

"Dosages of Concerta® will be defined according to the Swiss Compendium (from 18 to 72 mg/d).~The psychiatrist will start with the smallest dosage (18 mg) and will adapt it on a weekly basis or on need, depending on tolerance (side effects measured at each visit), clinical response (subjective improvement felt by the patient in terms of attention, impulsivity, and hyperactivity), and according to the observations made by the professionals or patient's entourage in term of attention, impulsivity, hyperactivity, and for this project, behavioral problems. In general, the dose can be increased in 18 mg at weekly intervals.~The treatment will be monitored weekly the first month, and then monthly, except for side effects which will be monitored daily in prison and every two weeks after release."

DRUG

Placebo

"The placebo will be strictly identical (same packaging, size no. 2 and color according to dosage, with no label).~Procedure for adjustment of dosage will be the same as in the Concerta arm."

Trial Locations (1)

1211

RECRUITING

Geneva University Hospitals, Geneva

All Listed Sponsors
collaborator

University of Lausanne

OTHER

collaborator

University of Geneva, Switzerland

OTHER

collaborator

Netherlands Institute for the Study of Crime

UNKNOWN

collaborator

School of Health Sciences Fribourg

UNKNOWN

lead

Stéphanie Baggio

OTHER